Dysphagia for medication in Parkinson's disease.

Autor: Labeit B; Department of Neurology with Institute of Translational Neurology, University Hospital Muenster, Muenster, Germany. Bendixruven.Labeit@ukmuenster.de.; Institute for Biomagnetism and Biosignal Analysis, University Hospital Muenster, Muenster, Germany. Bendixruven.Labeit@ukmuenster.de., Berkovich E; Clexio Biosciences LTD, Jerusalem, Israel., Claus I; Department of Neurology with Institute of Translational Neurology, University Hospital Muenster, Muenster, Germany., Roderigo M; Department of Neurology with Institute of Translational Neurology, University Hospital Muenster, Muenster, Germany., Schwake AL; Department of Neurology with Institute of Translational Neurology, University Hospital Muenster, Muenster, Germany., Izgelov D; Clexio Biosciences LTD, Jerusalem, Israel., Mimrod D; Clexio Biosciences LTD, Jerusalem, Israel., Ahring S; Department of Neurology with Institute of Translational Neurology, University Hospital Muenster, Muenster, Germany., Oelenberg S; Department of Neurology with Institute of Translational Neurology, University Hospital Muenster, Muenster, Germany., Muhle P; Department of Neurology with Institute of Translational Neurology, University Hospital Muenster, Muenster, Germany.; Institute for Biomagnetism and Biosignal Analysis, University Hospital Muenster, Muenster, Germany., Zentsch V; Department of Neurology with Institute of Translational Neurology, University Hospital Muenster, Muenster, Germany., Wenninger F; Department of Neurology with Institute of Translational Neurology, University Hospital Muenster, Muenster, Germany., Suntrup-Krueger S; Department of Neurology with Institute of Translational Neurology, University Hospital Muenster, Muenster, Germany.; Institute for Biomagnetism and Biosignal Analysis, University Hospital Muenster, Muenster, Germany., Dziewas R; Department of Neurology and Neurorehabilitation, Klinikum Osnabrueck - Academic teaching hospital of the WWU Muenster, Osnabrueck, Germany., Warnecke T; Department of Neurology and Neurorehabilitation, Klinikum Osnabrueck - Academic teaching hospital of the WWU Muenster, Osnabrueck, Germany.

Publikováno v: NPJ Parkinson's disease [NPJ Parkinsons Dis] 2022 Nov 12; Vol. 8 (1), pp. 156. Date of Electronic Publication: 2022 Nov 12.

Methodological Quality of Experimental Stroke Studies Published in the Stroke Journal: Time Trends and Effect of the Basic Science Checklist.

Autor: Minnerup J; From the Department of Neurology, University of Münster, Münster, Germany (J.M., V.Z., A.S.); Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (M.F.); and Department of Neurology, Bethel-Evangelisches Krankenhaus, Bielefeld, Germany (W.-R.S). minnerup@uni-muenster.de., Zentsch V; From the Department of Neurology, University of Münster, Münster, Germany (J.M., V.Z., A.S.); Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (M.F.); and Department of Neurology, Bethel-Evangelisches Krankenhaus, Bielefeld, Germany (W.-R.S)., Schmidt A; From the Department of Neurology, University of Münster, Münster, Germany (J.M., V.Z., A.S.); Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (M.F.); and Department of Neurology, Bethel-Evangelisches Krankenhaus, Bielefeld, Germany (W.-R.S)., Fisher M; From the Department of Neurology, University of Münster, Münster, Germany (J.M., V.Z., A.S.); Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (M.F.); and Department of Neurology, Bethel-Evangelisches Krankenhaus, Bielefeld, Germany (W.-R.S)., Schäbitz WR; From the Department of Neurology, University of Münster, Münster, Germany (J.M., V.Z., A.S.); Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (M.F.); and Department of Neurology, Bethel-Evangelisches Krankenhaus, Bielefeld, Germany (W.-R.S).

Publikováno v: Stroke [Stroke] 2016 Jan; Vol. 47 (1), pp. 267-72. Date of Electronic Publication: 2015 Dec 10.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Author Index.

Publikováno v: Movement Disorders; Sep2022 Supplement S1, Vol. 37, pS667-S699, 33p

PRIMED² Preclinical Evidence Scoring Tool to Assess Readiness for Translation of Neuroprotection Therapies.

Autor: Bahr-Hosseini, Mersedeh, Bikson, Marom, Iacoboni, Marco, Liebeskind, David S., Hinman, Jason D., Carmichael, S Thomas, Saver, Jeffrey L.

Publikováno v: Translational Stroke Research; Apr2022, Vol. 13 Issue 2, p222-227, 6p